Jiexin Li

Guangzhou, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 32 publications

Construction of precision clinical-proteomics risk model based on machine learning for predicting heart failure in type II diabetes mellitus.

Construction of precision clinical-proteomics risk model based on machine learning for predicting heart failure in type II diabetes mellitus.

Journal: Nutrition, metabolism, and cardiovascular diseases : NMCD

Published: January 22, 2026

PPARα activation overcomes fibroinflammatory liver microenvironment-associated anti-PD-1 resistance in hepatocellular carcinoma by mediating GSDME-dependent pyroptosis.

PPARα activation overcomes fibroinflammatory liver microenvironment-associated anti-PD-1 resistance in hepatocellular carcinoma by mediating GSDME-dependent pyroptosis.

Journal: Nature communications

Published: September 22, 2025

N6-methyladenosine attenuates tumor-associated macrophages M2 polarization via suppressing the translation of Snail.

N6-methyladenosine attenuates tumor-associated macrophages M2 polarization via suppressing the translation of Snail.

Journal: Science China. Life sciences

Published: January 13, 2025

N6-Methyladenosine Regulates Cilia Elongation in Cancer Cells by Modulating HDAC6 Expression.

N6-Methyladenosine Regulates Cilia Elongation in Cancer Cells by Modulating HDAC6 Expression.

Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)

Published: July 24, 2024

N6-methyladenosine RNA modification regulates the transcription of SLC7A11 through KDM6B and GATA3 to modulate ferroptosis.

N6-methyladenosine RNA modification regulates the transcription of SLC7A11 through KDM6B and GATA3 to modulate ferroptosis.

Journal: Journal of biomedical science

Published: July 22, 2024

BRD4 regulates m6A of ESPL1 mRNA via interaction with ALKBH5 to modulate breast cancer progression.

BRD4 regulates m6A of ESPL1 mRNA via interaction with ALKBH5 to modulate breast cancer progression.

Journal: Acta pharmaceutica Sinica. B

Published: June 25, 2024

RNA modifications in long non-coding RNAs and their implications in cancer biology.

RNA modifications in long non-coding RNAs and their implications in cancer biology.

Journal: Bioorganic & medicinal chemistry

Published: June 12, 2024

Small Molecule-Inducible and Photoactivatable Cellular RNA N1-Methyladenosine Editing.

Small Molecule-Inducible and Photoactivatable Cellular RNA N1-Methyladenosine Editing.

Journal: Angewandte Chemie (International ed. in English)

Published: December 26, 2023

Retraction Note: RNA m6A methylation regulates the epithelial mesenchymal transition of cancer cells and translation of Snail.

Retraction Note: RNA m6A methylation regulates the epithelial mesenchymal transition of cancer cells and translation of Snail.

Journal: Nature communications

Published: November 17, 2023

METTL3 promotes cellular senescence of colorectal cancer via modulation of CDKN2B transcription and mRNA stability.

METTL3 promotes cellular senescence of colorectal cancer via modulation of CDKN2B transcription and mRNA stability.

Journal: Oncogene

Published: July 25, 2023

N6-methyladenosine facilitates mitochondrial fusion of colorectal cancer cells via induction of GSH synthesis and stabilization of OPA1 mRNA.

N6-methyladenosine facilitates mitochondrial fusion of colorectal cancer cells via induction of GSH synthesis and stabilization of OPA1 mRNA.

Journal: National science review

Published: November 05, 2022

N1-methyladenosine modification in cancer biology: Current status and future perspectives.

N1-methyladenosine modification in cancer biology: Current status and future perspectives.

Journal: Computational and structural biotechnology journal

Published: August 10, 2022

Showing 1-12 of 32

Last Updated: 09/26/2026